How Merck Is Trying to Keep Disrupters at Bay
Harvard Business Review
JUNE 8, 2015
Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products. Experimentation is vital.
8 
Let's personalize your content